Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Zoetis Inc
ZTS | US
116.87
USD0.81
0.70%
ZTS | US
Loading StockChartView...
About Zoetis Inc
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
30/06/2024
As of date
24/04/2026
Close
116.87
Open
116.01
High
117.05
Low
115.41
Zoetis Inc. discovers develops manufactures and commercializes animal health medicines vaccines and diagnostic products in the United States and internationally. It commercializes products primarily across species including livestock such as cattle swine poultry fish and sheep and others; and companion animals comprising dogs cats and horses. The company also offers parasiticides; vaccines; anti-infectives; other pharmaceutical products; dermatology; and medicated feed additives. In addition the company provides animal health diagnostics including point-of-care diagnostic products and laboratory; and other non-pharmaceutical products. It markets its products to veterinarians livestock producers and pet owners. The company was founded in 1952 and is headquartered in Parsippany New Jersey.
View LessZTS | US
Risk
27.0
Sharpe
-0.95
Luna's Score
43/100
Recommendation
Sell
Luna says (ZTS | US)
What's Working
Strength based on increasing price with high volume
Largecap (10B - 200B USD)
Strong Operating Margin (> 25%)
What's not Working
Price Below SMA10D
High Short-term Volatility
Weak P/E, and PEG ratio indicator
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Rich in Valuation (Price to Book > 8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
29.1%1 month
27.0%3 months
27.1%6 months
31.8%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
37.90
Fwd. PE
30.86
Price to book
17.63
Debt to equity
1.36
Debt to assets
0.48
Ent. to EBITDA
25.53
Ent. to rev.
10.40
PEG
2.67
Other Fundamentals
EBITDA
3.64B
MarketCap
52.95B
MarketCap(USD)
52.95B
Div. yield
0.89
Op. margin
38.37
Erngs. growth
-5.50
Rev. growth
8.30
Ret. on equity
48.89
Short ratio
2.63
Short perc.
1.13
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
8.34
Range1M
9.99
Range3M
19.20
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.29
Price X volume
475.10M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 25.53 | 24.85 | Par |
| Ent. to Revenue | 10.40 | 361.91 | Cheaper |
| PE Ratio | 37.90 | 30.05 | Expensive |
| Price to Book | 17.63 | 13.15 | Expensive |
| Dividend Yield | 0.89 | 2.94 | Poor |
| Std. Deviation (3M) | 27.09 | 65.24 | Lower Risk |
| Debt to Equity | 1.36 | -1.88 | Expensive |
| Debt to Assets | 0.48 | 0.48 | Par |
| Market Cap | 52.95B | 3.71B | Market Leader |
